NEW YORK, July 12 - Pharmacopeia said Thursday that it is considering splitting its software business, Accelrys, off from its drug discovery businesses, as well as other strategic alternatives, to help the drug discovery operations expand independently of its collaborators and access a greater number of drug targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.